Rebecca G. Kim

Rebecca G. Kim, MD, MAS is an Assistant Professor in the Department of Internal Medicine at the University of Utah School of Medicine. She specializes in hepatology and health services research, focusing on chronic liver disease, liver transplantation, and social determinants of health (SDoH). Her clinical practice addresses alcohol-associated liver disease, metabolic dysfunction-associated steatotic liver disease (MASLD), and disparities in healthcare access for vulnerable populations.

• Medical Degree: University of Cincinnati College of Medicine
• Residency: University of California San Diego
• Chief Resident: University of California San Diego
• Fellowship: University of California San Francisco (Gastroenterology & Transplant Hepatology)
• Master in Advanced Studies (MAS) in clinical research with a specialization in Implementation Science: University of California San Francisco

Dr. Kim’s research explores how SDoH influence liver disease progression and outcomes, particularly for marginalized patients. She investigates strategies to address these disparities through implementation science and clinical interventions. Her recent work includes telehepatology applications, fatty liver education programs, and stigma reduction in patient care.

Her 15 most recent articles (2025–2012) span hepatology, oncology, public health, and molecular biology. Topics include chronic liver disease disparities, telemedicine efficacy, hepatitis C medication access, and genetic factors in cancer. These works reflect her focus on bridging clinical hepatology with health equity research.

Dr. Kim collaborates with leaders like Dr. Mandana Khalili (UCSF) and Drs. Jennifer Price (UCSF), Molly Conroy (University of Utah), and John Inadomi (University of Utah). Her career emphasizes patient-centered care, mentorship, and advancing health outcomes through interdisciplinary research.